A multicenter, randomized, double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase

Chinese Journal of Neurology

Volumn 40, Issue 5, 2007, Pages 306-310

  Ding, De Yun ^a   Lü, Chuan Zhen ^b   Ding, Mei Ping ^a   Su, Bing Hua ^b   Chen, Feng ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

Brain infarction; Kallikreins; Randomized controlled trials

Indexed keywords

EID: 42349110737     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke, 2006, 37: 63-68.
2. Sweetman SC. Martindale: the complete drug reference, 34th ed. London: Pharmaceutical Press, 2002: 836-837.
3. Nagano H, Suzuki T, Hayashi M, et al. Effects of a human urinary kininogenase (SK-827) on cerebral microcirculation after glass bead-induced cerebral embolism in rabbits. In Vivo, 1992, 6: 497-502.
4. Bonner, G, Schunk U, Preis S, et al. Effect of bradykinin on systemic and pulmonary hemodynamics in the human. Klin Wochenschr, 1989, 67: 1085-1095.
5. Hantson L, De Weerdt W, De Keyser J, et al. The European Stroke Scale. Stroke, 1994, 25: 2215-2219.
6. Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol, 2001, 28: 1060-1065.
7. Nagano H, Suzuki T, Nakamuru S, et al. Pharmacological studies on human urinary kallidinogenase (SK-827): cerebral protective effects. Yakugaku Zasshi, 1993, 113: 803-809.
8. Nagano H, Suzuki T, Tomoguri T, et al. Pharmacological studies on human urinary kallidinogenase (SK-827): effects on cerebral metabolism. Yakugaku Zasshi, 1993, 113: 825-828.
9. Xia CF, Yin H, Borlongan CV, et al. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension, 2004, 43: 452-459.
10. Suzuki T, Hirooka K, Nakamura S, et al. Pharmacological studies of human urinary kallidinogenase (SK-827): effects on arterial and regional blood flow. App Pharmacol, 1993, 45: 367-373.